Gilead Recent News
In Light Of Negative Sentiment, Gilead's Q1 Results Weren't So Bad
Endeavor Funds' Jerome Dodson Defends 3 Stocks Beaten Down In 2016
Gilead Trounces Hep C Estimates; Harvoni International Footprint Nearly Equals U.S.
Gilead Hits New 52-Week Low; Here Are Two Reasons Why
Gilead Sciences: Here's What A Bull And A Bear Are Saying
Gilead Sciences Remains Popular Post-Earnings
Is Gilead Sciences About To Buy Vertex For $45 Billion?
Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC Capital Says
UPDATE: Barclays Initiates Coverage On Gilead Sciences, 'Should Remain Ahead Of Its Peers'
How Did Analysts Get Gilead's Earnings Completely Wrong?
Market Wrap For March 27: Markets Lower Following Mixed Economic Data
How Much Does It Cost To Develop A New Drug?